Warren L.Nachlis Ph.D.

Partner

New York + 1.212.326.8364 Boston + 1.617.449.6941

Warren Nachlis focuses on licensing and technology transactional matters for clients worldwide.

His practice includes a wide range of intellectual property-related matters, including licensing, joint ventures, joint development agreements, sponsored research agreements with academic and nonprofit organizations, development and supply agreements, technology issues, and strategic intellectual property counseling. Warren also routinely advises clients on intellectual property issues that arise in connection with larger corporate transactions such as mergers and acquisitions, capital markets offerings, secured lending transactions, asset securitizations, and private equity investments.

Warren has experience in a broad spectrum of technology areas with particular emphasis in the pharmaceutical, biotechnology, medical device, electronics, media, entertainment, and financial information industries. His representative clients include Astellas, Astra Zeneca, Celgene, City of Hope, Essilor, Kyowa Kirin, REGENXBIO, sanofi-aventis, SAP, Verint Systems, and Visible Alpha. In addition, Warren's experience includes patent litigation and interference matters, and he has a strong technical background in polymers, pharmaceuticals, chemistry, and biology.

Warren is a member of the Licensing Committee of the Intellectual Property Owners Association.

Experience

  • Delaware North launches Gamewise joint venture partnership for sports betting and iGamingJones Day advised Delaware North in the formation of a joint venture with leading Belgian gaming and sports betting partner, GAMING1, for sports betting and iGaming.
  • Signature Aviation sells Global Engine Services business to StandardAero for $230 millionJones Day advised Signature Aviation plc, a market-leading provider of global aviation support services, in the $230 million sale of the Engine Repair and Overhaul (ERO) business to StandardAero, a portfolio company owned by The Carlyle Group and a leading provider of maintenance, repair, and overhaul services.
  • Delaware North sells Jumer’s Casino & Hotel to Bally's for $120 millionJones Day advised Delaware North, a global hospitality and entertainment company with operations in the sports, travel hospitality, restaurant and catering, lodging, gaming and specialty retail industries, in the sale of Jumer’s Casino & Hotel in Rock Island, Illinois, to Bally's Corporation for $120 million in cash.
  • Astellas returns rights to Eligard® in Europe, Middle East, CIS, and Asia to TolmarJones Day represented Astellas Pharma Europe Ltd. in connection with a series of transactions, including the sale of related assets, in which Astellas returned its in-licensing rights to Eligard® (leuprorelin acetate for injectable suspension), a treatment for advanced prostate cancer, sold by Astellas in Europe, the Middle East, the Commonwealth of Independent States (CIS) and Asia, to Tolmar International Limited.
  • Astellas Pharma acquires iota BiosciencesJones Day advised Astellas Pharma Inc. in its acquisition of iota Biosciences.
  • Hard Rock International acquires full intellectual property rights to Hard Rock Hotel & Casino® in Las Vegas in deal with Juniper CapitalJones Day advised Hard Rock International in its acquisition of all rights to the Hard Rock® brand and related trademarks in Las Vegas from private equity firm Juniper Capital.
  • VSE Corporation divests Prime Turbines, LLC to PTB Holdings USA, LLCJones Day advised VSE Corporation, a leading provider of distribution and repair services for land, sea, and air transportation assets in the public and private sectors, in the sale of subsidiary Prime Turbines, LLC to PTB Holdings USA, LLC.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • Hard Rock International acquires JACK Cincinnati Casino and Turfway Park for $745 millionJones Day advised Hard Rock International on the acquisition of JACK Cincinnati Casino, located in downtown Cincinnati, Ohio, together with VICI Properties, Inc., and Turfway Park, located in Florence, Kentucky, for an aggregate purchase price of approximately $745 million in cash.
  • Finacity Corporation acquired by Greensill CapitalJones Day advised Finacity Corporation, a leader in specialized receivables securitization, in its acquisition by Greensill Capital, the leading non-bank provider of working capital finance for companies globally.
  • Engage PEO acquired by Lightyear CapitalJones Day advised Engage PEO, a professional employer organization providing HR outsourcing solutions to small and mid-sized businesses across the U.S., in its acquisition by Lightyear Capital.
  • Bombardier acquires Global 7500 aircraft wing program from Triumph Group Inc.Jones Day advised Bombardier Inc. in its acquisition of the wing manufacturing operations and assets relating to Triumph Group Inc.’s Global 7500 wing program.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • GE Healthcare collaborates with Preventice Solutions Group to develop ambulatory cardiac arrhythmia monitoring suiteJones Day advised GE Healthcare in its collaboration with Preventice Solutions Group to develop an ambulatory cardiac arrhythmia monitoring suite for diagnostic purposes outside of hospitals or clinics.
  • Kenall sold to Legrand, North and Central AmericaJones Day advised Kenall Manufacturing, a leading manufacturer of innovative, energy efficient, and sustainable specification grade lighting and control solutions for commercial, industrial, and institutional buildings, in its sale of the Company to Legrand, North and Central America.
  • Adtalem Global Education sells DeVry UniversityJones Day advised Adtalem Global Education in the sale of DeVry University and its Keller Graduate School of Management to Cogswell Education, LLC, a company with significant experience in higher education.
  • Hyster-Yale sold PowerTap® hydrogen generator assets to OneH2Jones Day advised Hyster-Yale Materials Handling, Inc. in the sale by subsidiary, Nuvera Fuel Cells, LLC, of substantially all of its PowerTap® hydrogen generator assets, excluding related intellectual property, to OneH2, a hydrogen fuel company.
  • Strike Capital, LLC attempts business combination with Sentinel Energy Services Inc. to form publicly traded Strike Inc.Jones Day represented One Equity Partners (“OEP”) and Strike Capital, LLC (“Strike”) in the proposed sale of a majority interest in Strike to Sentinel Energy Services Inc., a special purpose acquisition company (“Sentinel”).
  • J.F. Lehman sells National Response Corporation and Sprint Energy Services to Hennessy Capital Acquisition Corp. IIIJones Day advised long standing client J.F. Lehman & Company, a leading mid-market private equity firm focused on the defense, aerospace, and maritime sectors, in connection with (i) the sale of all its membership interests in NRC Group Holdings, LLC, formed earlier this year through the combination of JFLCO portfolio companies National Response Corporation and Sprint Energy Services, to Hennessy Capital Acquisition Corp. III, and (ii) the related refinancing of the credit facilities of such portfolio companies.
  • HD Supply completes $750 million offering of Senior NotesJones Day represented HD Supply, Inc., one of the largest industrial distributors in North America, in connection with its issuance of $750 million in aggregate principal amount of 5.375% Senior Notes due 2026 in a Rule 144A and Regulation S offering.
  • Speaking Engagements

    • March 2015
      BIO Conference on International Taxation in the Biopharmaceutical Industry
    • November 13, 2013
      2013-2014 Life Sciences Webinar Series: Intellectual Property, Regulatory, and Antitrust Issues in Life Sciences M&A and Capital Markets Transactions